CSS
OPNT

Cubist Systematic Strategies’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Cubist Systematic Strategies’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,417
Closed -$216K – 3940
2021
Q4 		$216K Buy
+6,417
New +$179K ﹤0.01% 2988

Other funds holding OPNT

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $1.33B AUM 5.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cubist Systematic Strategies's OPNT Position: Q1 2022 in Review

Cubist Systematic Strategies sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2022, closing a stake of 6,417 shares — an estimated $216K sold.

Cubist Systematic Strategies first reported a position in OPNT in Q4 2021 and held it in 1 quarter. The position peaked at $216K in Q4 2021. 41 funds tracked by Wall St. Rank hold OPNT as of Q1 2022.

  • Cubist Systematic Strategies reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,417 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $216K.
  • Cubist Systematic Strategies first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Cubist Systematic Strategies's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $216K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.